Research
Hormonal
Indiscriminate use of Semaglutide for weight loss without medical supervision poses significant health risks, including gastrointestinal distress, hypoglycemia, and potential renal or pancreatic complications.
Do not use Semaglutide for weight loss without a doctor's prescription and monitoring. The risks, including severe stomach issues and low blood sugar, are significant when used indiscriminately. Sustainable weight loss requires lifestyle changes, not just medication.
ModerateRefutesMEDIUM confidence
O uso da semaglutida para fins de emagrecimento não está isento de riscos e pode acarretar consequências adversas à saúde dos pacientes.
Why this rating
It is a literature review citing various studies, but not a primary clinical trial itself.
Source
Riscos associados ao uso indiscriminado de Semaglutida (Ozempic)
Rosimeire Fernandes dos Santos et al. · Revista JRG de Estudos Acadêmicos · 2024
DOI 10.55892/jrg.v7i14.1185
narrative_reviewCited 6×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →